Versant Capital Management’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,604
| Closed | -$7.7K | – | 2718 |
|
|
2025
Q3 | $7.7K | Sell |
1,604
-289
| -15% | -$1.84K | ﹤0.01% | 2045 |
|
|
2025
Q2 | $17.2K | Sell |
1,893
-1,308
| -41% | -$9.64K | ﹤0.01% | 1610 |
|
|
2025
Q1 | $28.9K | Buy |
3,201
+2,699
| +538% | +$28.5K | ﹤0.01% | 1125 |
|
|
2024
Q4 | $6.56K | Buy |
502
+24
| +5% | +$320 | ﹤0.01% | 1622 |
|
|
2024
Q3 | $7.5K | Sell |
478
-341
| -42% | -$5.17K | ﹤0.01% | 1159 |
|
|
2024
Q2 | $11.1K | Hold |
819
| – | – | ﹤0.01% | 942 |
|
|
2024
Q1 | $22.7K | Hold |
819
| – | – | 0.01% | 468 |
|
|
2023
Q4 | $15.8K | Sell |
819
-720
| -47% | -$13K | ﹤0.01% | 570 |
|
|
2023
Q3 | $24.9K | Sell |
1,539
-54
| -3% | -$958 | 0.01% | 415 |
|
|
2023
Q2 | $30.3K | Buy |
1,593
+948
| +147% | +$16.9K | 0.01% | 387 |
|
|
2023
Q1 | $9.28K | Sell |
645
-420
| -39% | -$7.52K | ﹤0.01% | 734 |
|
|
2022
Q4 | $20.8K | Buy |
1,065
+348
| +49% | +$6.79K | 0.01% | 437 |
|
|
2022
Q3 | $17K | Buy |
717
+72
| +11% | +$2.22K | 0.01% | 472 |
|
|
2022
Q2 | $20K | Sell |
645
-31
| -5% | -$1.12K | 0.01% | 432 |
|
|
2022
Q1 | $30K | Buy |
676
+31
| +5% | +$1.33K | 0.01% | 366 |
|
|
2021
Q4 | $28K | Hold |
645
| – | – | 0.01% | 386 |
|
|
2021
Q3 | $20K | Hold |
645
| – | – | 0.01% | 481 |
|
|
2021
Q2 | $27K | Sell |
645
-1,180
| -65% | -$45.9K | 0.01% | 390 |
|
|
2021
Q1 | $69K | Sell |
1,825
-252
| -12% | -$7.88K | 0.03% | 199 |
|
|
2020
Q4 | $56K | Sell |
2,077
-204
| -9% | -$5.25K | 0.02% | 227 |
|
|
2020
Q3 | $57K | Sell |
2,281
-308
| -12% | -$4.49K | 0.03% | 200 |
|
|
2020
Q2 | $19K | Sell |
2,589
-44
| -2% | -$322 | 0.01% | 441 |
|
|
2020
Q1 | $24K | Buy |
2,633
+34
| +1% | +$205 | 0.01% | 320 |
|
|
2019
Q4 | $13K | Buy |
2,599
+14
| +0.5% | +$90 | 0.01% | 608 |
|
|
2019
Q3 | $15K | Buy |
2,585
+2,368
| +1,091% | +$10.6K | 0.01% | 564 |
|
|
2019
Q2 | $0 | Buy |
217
+96
| +79% | +$327 | ﹤0.01% | 1617 |
|
|
2019
Q1 | $0 | Sell |
121
-24
| -17% | -$152 | ﹤0.01% | 1690 |
|
|
2018
Q4 | $0 | Sell |
145
-152
| -51% | -$1.58K | ﹤0.01% | 1601 |
|
|
2018
Q3 | $4K | Sell |
297
-622
| -68% | -$10.6K | ﹤0.01% | 1162 |
|
|
2018
Q2 | $15K | Buy |
919
+811
| +751% | +$13.1K | 0.01% | 744 |
|
|
2018
Q1 | $1K | Buy |
+108
| New | +$1.93K | ﹤0.01% | 1396 |
|
|
2016
Q1 | – | Sell |
-8
| Closed | – | – | 1419 |
|
|
2015
Q4 | $0 | Buy |
+8
| New | +$289 | ﹤0.01% | 1403 |
|
Other funds holding ACH
CCM
ICM
PCMI
Versant Capital Management's ACH Position: Q4 2025 in Review
Versant Capital Management sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 1,604 shares — an estimated $7.7K sold.
Versant Capital Management first reported a position in ACH in Q4 2015 and held it in 32 quarters. The position peaked at $69K in Q1 2021. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.
- Versant Capital Management reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
- Versant Capital Management sold 1,604 Accendra Health shares in Q4 2025, an estimated $7.7K.
- Versant Capital Management first reported a position in Accendra Health in Q4 2015 and held it in 32 quarters.
- Versant Capital Management's Accendra Health position peaked at $69K in Q1 2021.
- 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.
Based on Versant Capital Management's 13F filing for Q4 2025, filed 8 Jan 2026.